Abcam news

Dec-2018

QIAGEN (Suzhou) and Abcam sign strategic MoU collaboration agreement to co-develop companion diagnostic (CDx) and in vitro diagnostic (IVD) reagents and kits for the Chinese market

Dec-2018

Abcam 'Most Admired Company' award

Oct-2018

Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development

Oct-2018

New PBS-only antibodies enable more flexible research

Jul-2018

Abcam Merck collaboration produces new PD-L1 antibody for immuno-oncology research

Jun-2018

Congratulations to Alan Hirzel, winner of European Mediscience Awards Chief Executive of the year award

Apr-2018

Abcam and Shuwen Biotech sign strategic MoU to establish global alliance for companion diagnostic (CDx) kit development

Feb-2018

New CatchPoint® SimpleStep® ELISA fluorescent 90-minute assay

Feb-2018

Introducing FirePlex®-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples

Feb-2018

Abcam and Molecular Devices announce strategic collaboration

Jan-2018

Abcam wins another CiteAb award

Jan-2018

Abcam signs exclusive license agreement with Roche

Aug-2017

Abcam and TTP Labtech collaborate to develop sol-R reagent kits

Jul-2017

The University of Bath enters licensing agreement with Abcam to develop fluorescent detection probe kit for sugar-damaged proteins

Jun-2017

Abcam announces first international Epigenetics conference in South Korea

Jan-2017

Abcam wins two CiteAb awards

Nov-2016

Abcam wins Best Careers Website at the In-house Recruitment Awards

Jul-2016

New multiplex immunoassays with Firefly® particle technology

Apr-2016

Abcam enables faster drug and biomarker discovery with immunoassay research suite

Feb-2016

Congratulations to Jonathan Milner, winner of CiteAb’s Lifetime achievement award

Nov-2015

Abcam offers direct service to Singapore as part of deepening commitment to Asia-Pacific researchers

Nov-2015

Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership

Oct-2015

Abcam’s new anti-PD-L1 antibody enables deeper insights into cancer immunology research

Sep-2015

Abcam raises antibody validation standards to improve quality for life science researchers

Jun-2015

Appointment of Chief Legal Officer and Company Secretary

Jun-2015

Abcam launches multiplex miRNA profiling assays

Jan-2015

Abcam signs exclusive partnership agreement with A*STAR's Institute of Molecular and Cell Biology

Dec-2014

Sue Harris appointed as non-Executive Director on Abcam Board

Dec-2014

Abcam appoints Yvonne Chien as Chief Digital Officer

Nov-2014

Abcam wins 'Best Use of Digital Media' at Life Science Industry Awards

Sep-2014

Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute

Sep-2014

Abcam plc announces appointment of new CEO and Board changes

Sep-2014

Abcam and Cell Marque sign global strategic marketing agreement for IVD IHC RabMAb® antibodies

Sep-2014

Abcam introduces exclusive range of highly validated antibody conjugates

Aug-2014

Abcam establishes new direct service for Australia and New Zealand

Jun-2014

Abcam's CEO wins Mediscience award

Mar-2014

Abcam introduces Alexa Fluor® 680/790 secondary antibodies for fluorescent western blotting

Feb-2014

Abcam Announces Winner of 15 Discoveries Contest

Jan-2014

Abcam to open office in Shanghai, China

Dec-2013

Abcam wins 'Most Admired Company' award

Nov-2013

Abcam Introduces Alexa Fluor Secondary Antibodies

Oct-2013

Abcam Named AIM Company of the Year

Sep-2013

Abcam Launches SimpleStep ELISA Kits

Jun-2013

Abcam appoints Alan Hirzel as Chief Marketing Officer

Apr-2013

Abcam Welcomes Students from Cambridge Regional College

Mar-2013

Abcam donates an additional £45,000 to local charities

Dec-2012

Abcam helps contribute to growth of hi-tech sector in Cambridge, UK

Nov-2012

We have reached 100,000 products

Oct-2012

HRH The Duke of York visits Abcam to see the Cambridge Phenomenon in action

Sep-2012

Rabbit monoclonal antibodies, available from Abcam following acquisition of Epitomics

Jan-2012

New range of Biochemicals now available from Abcam

Sep-2011

Abcam acquires Ascent Scientific, a specialist provider of biochemicals

May-2011

Abcam acquires MitoSciences in deal which enhances immunoassay portfolio

Nov-2010

Jonathan Milner wins Entrepreneur of the Year award.

Jul-2010

Abcam's Jonathan Milner wins CEO of the Year

Jul-2010

300th employee hired

Mar-2010

Abcam wins 'Business of the Year 2009' at the Business Weekly East of England Awards.

Feb-2010

Abcam founder wins 'CEO of the Year' at Quoted Company Awards 2010

Jan-2010

Abcam and Cambridge Design Partnership develop innovative labeling solution

Oct-2009

Abcam named 'Company of the Year' at 2009 AIM Awards

Jun-2009

Abcam’s expansion continues with its fourth move on the Cambridge Science Park

Nov-2008

Winners of tenth anniversary competition announced

Jul-2008

200th employee hired

May-2008

Licensing deal signed with Tepnel Life Sciences

Mar-2008

Grand setting for Japanese sub-dealer meetings

Nov-2007

Automated system to expand monoclonal production

Nov-2007

Abcam and leading antibody producer collaborate to make 12,000 rabbit polyclonals

Nov-2007

CLC bio customized software supports Abcam's monoclonal development capability

Nov-2007

Jeffrey Iliffe appointed as Chief Financial Officer

May-2007

Same day delivery in Cambridge UK

Mar-2007

Over 30,000 products in our catalog

Mar-2007

Abcam to partner in the EPITRON project

Jan-2007

$2 to Médecins Sans Frontières for every new registration

Jul-2006

Extra Abpoints introduced for first Abreviews

Jul-2006

Appointment of Non-Executive Directors

Jun-2006

Winner of Best Newcomer in the UK techMARK mediscience awards

May-2006

Better antibodies, faster

Feb-2006

Winner of Private Company of the Year, Business Weekly East of England Business Awards 2005

Feb-2006

20,000+ products, 1,300 new lysates, Abpromise stats, Abupdate & news

Jan-2006

Fast Abpromise support, free loading control samples, Abupdate & news

Nov-2005

Search filter, conjugated loading controls, Abupdate & news

Oct-2005

Extended North America customer service hours

Sep-2005

Top forty position, Sunday Times Microsoft Tech Track

May-2005

US office on the move

Apr-2005

Queen's Award at first attempt

Apr-2005

More space

Dec-2004

A faster service

Oct-2004

First place in Deloitte's Fast 50

Sep-2004

50th employee hired

Sep-2004

Top forty position, Sunday Times Microsoft Tech Track

Jun-2004

Jim Warwick becomes Managing Director (Abcam Ltd)

Feb-2004

Collaboration deal struck with Purely Proteins

Jan-2004

A New Year's Honour

Dec-2003

High growth status recognised again, this time nationally

Oct-2003

Success in Deloitte's Regional Technology Fast 50

Sep-2003

Top twenty position, Sunday Times Arm Tech Track

Jul-2003

British royalty visits Abcam

May-2003

First overseas office established

Apr-2003

Jim Warwick (Technical Director) becomes full-time

Mar-2003

CEN Business Excellence Awards winner

Mar-2003

25th employee hired

Feb-2003

On the move again

Nov-2002

Deloitte Top 50 regional winner

Aug-2002

FedEx tie-up boosts customer support services

Jun-2001

Technical Director appointed

May-2001

UK Online for Business Award, highly commended

Oct-2000

CEN Millennium Business Excellence Awards finalist

May-2000

10th employee hired

Apr-2000

Finance Director appointed

Mar-2000

New premises on the Cambridge Science Park

Oct-1999

First (of many) awards

Oct-1998

Open for business